SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

HC Wainwright & Co. Reiterates Buy on Sutro Biopharma, Lowers Price Target to $17

HC Wainwright & Co. reiterates Sutro Biopharma (NASDAQ:STRO) with a Buy and lowers the price target from $18 to $17.

Benzinga · 05/13/2020 11:34

HC Wainwright & Co. reiterates Sutro Biopharma (NASDAQ:STRO) with a Buy and lowers the price target from $18 to $17.